Structural and functional analysis of cyclin D1 reveals p27 and substrate inhibitor binding requirements

ACS Chemical Biology

Volumn 5, Issue 12, 2010, Pages 1169-1182

  Liu, Shu ^a   Bolger, Joshua K ^a   Kirkland, Lindsay O ^a   Premnath, Padmavathy N ^a   McInnes, Campbell ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; CYCLIN A; CYCLIN A2; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 7; CYCLIN DEPENDENT KINASE 9; PROTEIN P27; TRANSCRIPTION FACTOR E2F;

ARTICLE; CELL CYCLE; ENZYME ACTIVITY; ENZYME SPECIFICITY; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION;

CRYSTALLOGRAPHY, X-RAY; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; STRUCTURAL HOMOLOGY, PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 78650562602     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb1001262     Document Type: Article

References (26)

1. Sherr, C. J. (1996) Cancer cell cycles Science 274, 1672-1677
2. Malumbres, M. and Barbacid, M. (2001) To cycle or not to cycle: a critical decision in cancer Nat. Rev. Cancer 1, 222-231
3. McInnes, C., Andrews, M. J. I., Zheleva, D. I., Lane, D. P., and Fischer, P. M. (2003) Peptidomimetic design of CDK inhibitors targeting the recruitment site of the cyclin subunit Curr. Med. Chem.: Anti-Cancer Agents 3, 57-69
4. WAF1 derived peptide inhibitors of CDK-mediated pRb phosphorylation: delineation and structural insight into their interactions with cyclin A J. Peptide Res. 60, 257-270
5. Chen, Y. N., Sharma, S. K., Ramsey, T. M., Jiang, L., Martin, M. S., Baker, K., Adams, P. D., Bair, K. W., and Kaelin, W.G., Jr. (1999) Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists Proc. Natl. Acad. Sci. U.S.A. 96, 4325-4329
6. Schulman, B. A., Lindstrom, D. L., and Harlow, E. (1998) Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A Proc. Natl. Acad. Sci. U.S.A. 95, 10453-10458
7. Ball, K. L., Lain, S., Fåhraeus, R., Smythe, C., and Lane, D. P. (1996) Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1 Curr. Biol. 7, 71-80
8. Mendoza, N., Fong, S., Marsters, J., Koeppen, H., Schwall, R., and Wickramasinghe, D. (2003) Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from atp site inhibitors block tumor growth Cancer Res. 63, 1020-1024
9. Oelgeschlager, T. (2002) Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control J. Cell. Physiol. 190, 160-169
10. Fischer, P. M. and Gianella-Borradori, A. (2005) Recent progress in the discovery and development of cyclin-dependent kinase inhibitors Expert Opin. Invest. Drugs 14, 457-477
11. Baughn, L. B., Di Liberto, M., Wu, K., Toogood, P. L., Louie, T., Gottschalk, R., Niesvizky, R., Cho, H., Ely, S., Moore, M. A., and Chen-Kiang, S. (2006) A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6 Cancer Res. 66, 7661-7667
12. Fry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M., Trachet, E., Albassam, M., Zheng, X., Leopold, W. R., Pryer, N. K., and Toogood, P. L. (2004) Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts Mol. Cancer Ther. 3, 1427-1438
13. Yu, Q., Sicinska, E., Geng, Y., Ahnstrom, M., Zagozdzon, A., Kong, Y., Gardner, H., Kiyokawa, H., Harris, L. N., Stal, O., and Sicinski, P. (2006) Requirement for CDK4 kinase function in breast cancer Cancer Cell 9, 23-32
14. Landis, M. W., Pawlyk, B. S., Li, T., Sicinski, P., and Hinds, P. W. (2006) Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis Cancer Cell 9, 13-22
15. Kontopidis, G., Andrews, M. J. I., McInnes, C., Cowan, A., Powers, H., Innes, L., Plater, A., Griffiths, G., Paterson, D., Zheleva, D. I., Lane, D. P., Green, S., Walkinshaw, M. D., and Fischer, P. M. (2003) Insights into cyclin groove recognition: complex crystal structures and inhibitor design through ligand exchange Structure 11, 1537-1546
16. Andrews, M. J. I., McInnes, C., Kontopidis, G., Innes, L., Cowan, A., Plater, A., and Fischer, P. M. (2004) Design, synthesis, biological activity and structural analysis of cyclic peptide inhibitors targeting the substrate recruitment site of cyclin-dependent kinase complexes Org. Biomol. Chem. 2, 2735-2341
17. Andrews, M. J., Kontopidis, G., McInnes, C., Plater, A., Innes, L., Cowan, A., Jewsbury, P., and Fischer, P. M. (2006) REPLACE: a strategy for iterative design of cyclin-binding groove inhibitors ChemBioChem 7, 1909-1915
18. Brown, N. R., Noble, M. E., Endicott, J. A., and Johnson, L. N. (1999) The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases Nat. Cell Biol. 1, 438-443
19. Day, P. J., Cleasby, A., Tickle, I. J., O'Reilly, M., Coyle, J. E., Holding, F. P., McMenamin, R. L., Yon, J., Chopra, R., Lengauer, C., and Jhoti, H. (2009) Crystal structure of human CDK4 in complex with a D-type cyclin Proc. Natl. Acad. Sci. U.S.A. 106, 4166-4170
20. Takaki, T., Echalier, A., Brown, N. R., Hunt, T., Endicott, J. A., and Noble, M. E. (2009) The structure of CDK4/cyclin D3 has implications for models of CDK activation Proc. Natl. Acad. Sci. U.S.A. 106, 4171-4176
21. Kontopidis, G., Andrews, M. J., McInnes, C., Plater, A., Innes, L., Renachowski, S., Cowan, A., and Fischer, P. M. (2009) Truncation and optimization of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design ChemMedChem 4, 1120-1128
22. Castanedo, G., Clark, K., Wang, S., Tsui, V., Wong, M., Nicholas, J., Wickramasinghe, D., Marsters, J. C., Jr., and Sutherlin, D. (2006) CDK2/cyclinA inhibitors: targeting the cyclinA recruitment site with small molecules derived from peptide leads Bioorg. Med. Chem. Lett. 16, 1716-1720
23. Blain, S. W. (2008) Switching cyclin D-Cdk4 kinase activity on and off Cell Cycle 7, 892-898
24. James, M. K., Ray, A., Leznova, D., and Blain, S. W. (2008) Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity Mol. Cell. Biol. 28, 498-510
25. Ray, A., James, M. K., Larochelle, S., Fisher, R. P., and Blain, S. W. (2009) p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes Mol. Cell. Biol. 29, 986-999
26. Russo, A. A., Jeffrey, P. D., Patten, A. K., Massague, J., and Pavletich, N. P. (1996) Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex Nature 382, 325-331